 Parent Directory | | |
![[TXT]](/_autoindex/assets/icons/file-text.svg) _opq_export-2026-04-23.html | 2026-04-24 02:44 | 37k |
 Q-218, COVID-19 vaccines and recommendations for pregnancy, differing from US... | 2026-04-19 00:52 | 4925k |
| Q-223 (Order), deaths and autopsies, Sep 2025.pdf | 2026-04-19 00:52 | 691k |
| Q-224_HC, One Health approach, Sep 2025.pdf | 2026-04-19 00:52 | 238k |
| Q-225_HC, impurities, LNPs, Sep 2025.pdf | 2026-04-19 00:51 | 232k |
| Q-229_HC, confidentiality agreements of PHAC personnel, Sep 2025.pdf | 2026-04-19 00:51 | 179k |
| Q-230 Action Committee, October 2025.pdf | 2026-04-19 00:52 | 737k |
| Q-283 the PfizerBioNtech Phase 3 vaccine clinical trial.pdf | 2026-04-19 00:54 | 55k |
| Q-402, federal employees and COVID-19 pandemic.pdf | 2026-04-19 00:55 | 683k |
| Q-408, November 19, 2025 changes to the Vaccine Injury Support program and a... | 2026-04-19 00:49 | 207k |
| Q-459 December 3, 2025, adverse events and reproductive health COVID 19 vacc... | 2026-04-19 00:49 | 240k |
| Q-460, December 3, 2025, number of vaccine injury reports and amount of comp... | 2026-04-19 00:49 | 196k |
| Q-463, when gov't became aware vaccines did not prevent infection or transmis... | 2026-04-19 00:55 | 325k |
| Q-464, clinical trial data.pdf | 2026-04-19 00:55 | 380k |
| Q-518 - Expenses to cull ostriches at Edgewood farm, January 26, 2026.pdf | 2026-04-19 00:55 | 299k |
| Q-561 - Access to information wait times, January 26, 2026 for .pdf | 2026-04-19 00:50 | 1033k |
| Q-580 - COVID-19 Mandate grievances, suspensions and terminations, January 2... | 2026-04-19 00:50 | 4466k |
| Q-638 - COVID-19 vaccine procurement, January 26, 2026.pdf | 2026-04-19 00:55 | 211k |
| Q-660 - COVID-19 response targeting indigenous population, January 26, 2026.pdf | 2026-04-19 00:49 | 273k |
| Q-668 - Joint projects between Dept of Defense and PHAC, January 26, 2026.pdf | 2026-04-19 00:50 | 548k |
| Q-668 -Projects between PHAC and Dept of Defense, January 26, 2026.pdf | 2026-04-19 00:50 | 548k |
| Q-669 - Biosecurity threats, pathogens and LABS in Canada, January 26, 2026.pdf | 2026-04-19 00:50 | 436k |
| Q-733 - behavioural science experiments and nudging, January 26, 2026.pdf | 2026-04-19 00:50 | 511k |
| Q-738 - excluded immigration medical exam exemptions during COVID, January 26... | 2026-04-19 00:50 | 204k |
| Q-763 - Benefits of the vaccine outweigh risks, Response from March 11, 2026-... | 2026-04-19 00:50 | 88k |
| Q-764 -Lipid nanoparticles, Response from March 11, 2026.pdf | 2026-04-19 00:50 | 197k |
| Q-766 - Myocarditis and pericarditis and the covid vaccine, Response from Mar... | 2026-04-19 00:50 | 379k |
| Q-767 - myocarditis and pericarditis and international cluster meetings, Resp... | 2026-04-19 00:50 | 292k |
| Q-848 -Cost of research re- the safety of the COVID-19 vaccines April 13, 202... | 2026-04-19 00:47 | 353k |
| Q-849 - Why PHAC counted Cases following vaccination starting from 14 DEC 202... | 2026-04-19 00:47 | 228k |
| Q-850, Department of National Defence deaths and sick leave, April 13, 2026.pdf | 2026-04-19 00:47 | 1970k |
| Q-879 - PHAC and assumption of the VISP program, April 13, 2026.pdf | 2026-04-19 00:47 | 191k |
| Q-911 - government advertising campaigns abroad, April 13, 2026.pdf | 2026-04-19 00:47 | 1725k |